Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-14

Clinical Trial Update: Oral Zinc Gluconate as Treatment for Recalcitrant Cutaneous Warts: A Randomized, Double-blind, Placebo-controlled Trial [Phase 2, Phase 3]

View source ↗

Summary

A randomized, double-blind, placebo-controlled trial evaluated oral zinc gluconate for recalcitrant cutaneous warts and has completed its Phase 2/3 program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zinc gluconate (zinc gluconate)

Snippet

Sponsor: Philippine Dermatological Society | Conditions: Recalcitrant Cutaneous Warts | Phase 2, Phase 3 | Status: COMPLETED